Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

Go back to Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study
(NASDAQ: LEXX) Delayed: 5.79 --0 (-0%)
Previous Close $5.79    52 Week High
Open $5.79    52 Week Low
Day High $5.79    P/E N/A 
Day Low $5.79    EPS
Volume 15,544